Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Squamous Cell Carcinoma of the Head and Neck”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT03525392
What this trial is testing

Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1.

Who this might be right for
Pancreatic Ductal AdenocarcinomaColorectal CancerGastric Cancer+5 more
Ipsen 14
Testing effectiveness (Phase 2)UnknownNCT05027204
What this trial is testing

Docetaxel for Injection (Albumin-bound) in Combination With Nivolumab in Patients With Head and Neck (SCCHN)

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 94
Testing effectiveness (Phase 2)Study completedNCT01816984
What this trial is testing

PI3K Inhibitor BKM120 and Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+33 more
University of Chicago 12
Testing effectiveness (Phase 2)Study completedNCT02319044
What this trial is testing

Phase II Study of MEDI4736, Tremelimumab, and MEDI4736 in Combination w/ Tremelimumab Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Recurrent/Metastatic Squamous Cell Carcinoma of Head & Neck
AstraZeneca 267
Early research (Phase 1)Study completedNCT03219268
What this trial is testing

MGD013 in Patients With Unresectable or Metastatic Neoplasms

Who this might be right for
Advanced Solid TumorsHematologic NeoplasmsOvarian Cancer+7 more
MacroGenics 277
Early research (Phase 1)Study completedNCT01353625
What this trial is testing

Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies.

Who this might be right for
Glioblastoma MultiformeSquamous Cell Carcinoma of Head and NeckProstate Cancer+3 more
Celgene 118
Large-scale testing (Phase 3)Study completedNCT00401323
What this trial is testing

Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck NeoplasmsNeoplasm Recurrence, LocalNeoplasm Metastasis
Sanofi 568
Large-scale testing (Phase 3)Study completedNCT02369874
What this trial is testing

Study of MEDI4736 Monotherapy and in Combination With Tremelimumab Versus Standard of Care Therapy in Patients With Head and Neck Cancer

Who this might be right for
Recurrent or Metastatic PD-L1-positive or -Negative Squamous Cell Carcinoma of the Head and Neck SCCHN
AstraZeneca 736
Not applicableUnknownNCT00173381
What this trial is testing

The Role of Lymphangiogenesis in Head and Neck Cancer Metastasis

Who this might be right for
Oral CancerLaryngeal CancerHypopharyngeal Cancer
National Taiwan University Hospital 100
Testing effectiveness (Phase 2)Looking for participantsNCT05877430
What this trial is testing

Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer

Who this might be right for
NSCLCHNSCCMelanoma+3 more
CJ Bioscience, Inc. 160
Testing effectiveness (Phase 2)Looking for participantsNCT07136545
What this trial is testing

A Phase I/II Trial of HCB101 in Combination With Pembrolizumab for Patients With Platinum-Refractory, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (SirH&N Trial)

Who this might be right for
HNSCC
Taipei Veterans General Hospital, Taiwan 50
Testing effectiveness (Phase 2)Study completedNCT00006245
What this trial is testing

Flavopiridol and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer That Has Not Responded to Previous Paclitaxel

Who this might be right for
Esophageal Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT06494995
What this trial is testing

AK104 and Low-dose Radiation in Recurrent/Metastatic HNSCC After Failure of First-line Systemic Therapy

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Fudan University 52
Testing effectiveness (Phase 2)Looking for participantsNCT06052839
What this trial is testing

Pulsed Dose Chemotherapy Plus Pembrolizumab in Recurrent/Metastatic HNSCC

Who this might be right for
Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
Dan Zandberg 15
Testing effectiveness (Phase 2)Study completedNCT00006248
What this trial is testing

S0007 - Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
SWOG Cancer Research Network 78
Testing effectiveness (Phase 2)UnknownNCT05189184
What this trial is testing

Study of Camrelizumab in Combination With Apatinib Mesylate Plus Albumin-bound Paclitaxel and Cisplatin as the First Line Treatment of Recurrent or Metastatic, UnresectableHead and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
The First Affiliated Hospital of Zhengzhou University 30
Early research (Phase 1)Looking for participantsNCT06540443
What this trial is testing

Pilot Study of MPB-2043 Enhanced MRI for Nodal Staging in Head and Neck Squamous Cell Carcinomas

Who this might be right for
Head and Neck Squamous Cell CarcinomaLymph Node Metastasis
MegaPro Biomedical Co. Ltd. 24
Large-scale testing (Phase 3)Active Not RecruitingNCT06496178
What this trial is testing

Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Merus B.V. 621
Large-scale testing (Phase 3)Study completedNCT03430843
What this trial is testing

Tislelizumab (BGB-A317) Versus Chemotherapy as Second Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
BeiGene 512
Early research (Phase 1)Study completedNCT02350712
What this trial is testing

Patritumab With Cetuximab and a Platinum Containing Therapy for Patients With Head and Neck Cancer

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Daiichi Sankyo 15
Next Page